Pancreatic Cancer Research

ResearcherShiraz University of Medical SciencesActive in the last 2 years

H. Heli

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0003-1753-1193; OpenAlex author ID A5044916380.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 2)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Labs led
1
Collaborators
2
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Investigation of bioavailability and anti-pancreatic cancer efficacy of a self-nanoemulsifying erlotinib delivery system. Last author DOI 10.1080/20415990.2025.2466412↗
  2. Erlotinib-loaded albumin nanoparticles: A novel injectable form of erlotinib and its in vivo efficacy against pancreatic adenocarcinoma ASPC-1 and PANC-1 cell … Last author DOI 10.1016/j.ijpharm.2017.08.102↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Maryam Karimi · 1 shared paper, 2025
  2. M. Noorani · 1 shared paper, 2017

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.